STAGE IB2–IIIB CERVICAL CANCER: NEOADJUVANT CHEMOTHERAPY, RADICAL SURGERY AND PATIENT SURVIVAL

STAGE IB2–IIIB CERVICAL CANCER: NEOADJUVANT CHEMOTHERAPY, RADICAL SURGERY AND PATIENT SURVIVAL

The aim of the study was to evaluate the five-year survival rate in patients with stage ib2–iiib cervical cancer treated with neoadjuvant chemotherapy and radical surgery.Material and Methods. Long-term treatment outcomes were studied in 173 patients with histologically-verified stage ib2–iiib cervi...

Full description

Saved in:
Bibliographic Details
Main Authors: D. L. Ovodenko, G. N. Khabas, Yu. M. Kreinina, A. A. Seregin, O. I. Aleshikova, L. A. Ashrafyan
Format: Article
Language:Russian
Published: Russian Academy of Sciences, Tomsk National Research Medical Center 2021-06-01
Series:Сибирский онкологический журнал
Subjects:
cervical cancer
neoadjuvant chemotherapy
radical hysterectomy
disease-free survival
chemoembolization
Online Access:https://www.siboncoj.ru/jour/article/view/1813
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://www.siboncoj.ru/jour/article/view/1813

Similar Items